In agreement with these reports, cBioportal analysis of data on somatic copy number variation and mRNA level using TCGA endometrial and ovarian cancer dataset demonstrated that PD-L1 is indeed co-amplified along with MYC, SOX2, N-cadherin and SNAI1 in both cancer types (Figure 2A). This evidence concerns the gene CDH2 and cancer.